MedPath

Intraperitoneal Mesh-Implementation After Laparotomy

Not Applicable
Conditions
Incisional Hernia
Interventions
Device: Mesh implementation
Registration Number
NCT01003067
Lead Sponsor
Kantonsspital Liestal
Brief Summary

Aim of the study is to evaluate the risk reduction of intraperitoneal mesh-implementation after laparotomy (Group 1) in a randomized control trial compared with patients with standard abdominal closure (Everett-suture). This is the primary endpoint. Second endpoints are the feasibility of mesh-implementation even after colorectal surgery, find risk factors for wound infection and incisional hernia.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
267
Inclusion Criteria
  • Informed consent
  • Median Laparotomy
Exclusion Criteria
  • Bowel perforation
  • Pregnancy
  • Palliative surgery
  • Drug abuse
  • Age under 18
  • Mental disability
  • Allergy to mesh components

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mesh ImplementationMesh implementation-
Primary Outcome Measures
NameTimeMethod
Number of Participants With Incisional Hernia At 2 Years Following Median Laparotomy2 years

Primary endpoint was the incidence of incisional hernias at 2 years following midline laparotomy.

Secondary Outcome Measures
NameTimeMethod
Feasibility of Mesh-implementation Even After Colorectal Surgery, Find Risk Factors for Wound Infection and Incisional Hernia.5 Years

Secondary endpoints are the feasibility, the safety of the mesh stripe implantation including postoperative pain, and the incidence of incisional hernias at 5 years.

Trial Locations

Locations (1)

Kantonsspital Liestal

🇨🇭

Liestal, BL, Switzerland

© Copyright 2025. All Rights Reserved by MedPath